Join us   Log in  

PHARMASPIRE - Volume 12, Issue 2, April - June, 2020

Pages: 72-78

Date of Publication: 14-Jun-2022

Print Article   Download XML  Download PDF

Formulation, optimization, and characterization of solid lipid dispersion

Author: Lovepreet Kaur, Vineet Kumar Rai, Raj Kumar Narang, Tanmay S. MarkandeywarLovepreet Kaur, Tanmay S. Markandeywar

Category: Pharmaceutics


Aim: Present work was permeation enhancement of metformin hydrochloride using solid lipid dispersion (SLD) technique. Method: The SLD was prepared by coprecipitation method. SLD was prepared at ratio of drug: lipid carrier 1:14 (% w/w) by coevaporation method. Result: Prepared SLD was optimized and characterized by various parameters such as particle size, zeta potential, transmission electron microscopy, Fourier transform infrared, and percent entrapment efficiency. SLD had an optimum particle size and showed good stability. Differential scanning calorimetry showed that drug might exist in amorphous form. The maximum amount of drug was entrapped in SLD. In vitro release study revealed that minimum amount of drug was released in the first 2 h in simulated gastric fluid (pH 1.2) and maximum amount of drug was released up to 24 h in simulated intestinal fluid (pH 6.8). Ex vivo studies of plain drug and SLD showed that SLD had better intestinal permeability. Conclusion: SLD shows enhancement of intestinal permeability in turns to increase oral bioavailability.

Keywords: Permeation enhancement, coprecipitation, metformin, solid lipid dispersion


1. Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. Aaps Pharm SciTech 2010;11:518-27.

2. Kaur J, Aggarwal G, Singh G, Rana AC. Improvement of drug solubility using solid dispersion. Int J Pharm Pharm Sci 2012;4:47-53.

3. Dixit ND, Niranjan SK. A Review: Solid dispersion. World J Pharm Pharm Sci 2014;3:238-57.

4. Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 2010;27:1469-86.

5. Rawat M, Singh D, Saraf S, Saraf S. Lipid carriers: A versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 2008;128:269-80.

6. Fong SY, Brandl M, Bauer-Brandl A. Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis. Eur J Pharm Sci 2015;80:89-110.

7. Weyhers H, Ehlers S, Hahn H, Souto EB, Müller RH. Solid lipid nanoparticles (SLN) effects of lipid composition on in vitro degradation and in vivo toxicity. Pharmazie 2006;61:539-44.

8. El-Leithy ES, Nasr M, El-Moneum RA. Development and characterization of solid lipid dispersion as delivery system for hydrophilic antihypertensive drug atenolol. Int J Drug Deliv 2012;4:219.

9. Affandi MM, Julianto T, Majeed A. Development and stability evaluation of astaxanthin nanoemulsion. Asian J Pharm Clin Res 2011;4:142-8.

10. Prasad RS, Yandrapu SK, Manavalan R. Lipid solid dispersions for the aqueous solubility and bioavailability enhancement of entacapone. Asian J Chem 2010;22:4549.

11. Priya MR, Jeevitha N. Semi-solid dispersion of carvedilol solid lipid nanoparticles for topical delivery. Eur J Pharm Med Res 2016;3:231-8.

12. Ekambaram P, Sathali AA. Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm 2011;3:216-20.